Found 54 matching trials
Fucoidan in the Treatment of Active Rheumatoid Arthritis NA Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients NA A prospective, multi-centric, cohort study to observe the efficacy differen...
Show More Location
The Second Xiangya Hospital of Central South University
Learn More & Join Trial
A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs N/A The purpose of this Italian multicenter study is to collect prospective cli...
Show More Location
ASST Spedali Civili Brescia
Learn More & Join Trial
L-carnitine Supplementation in Rheumatoid Arthritis Patients PHASE2 This study aims to evaluate the effect of l-carnitine as add- on therapy fo...
Show More Location
Demerdash hospital
Learn More & Join Trial
Ultrasound in Psoriatic Arthritis Treatment N/A BACKGROUND Psoriatic arthritis (PsA) is a systemic inflammatory disease wit...
Show More Location
Azienda Ospedaliera Universitaria
Learn More & Join Trial
A Study of Iguratimod in Combination With Tofacitinib in RA Patients PHASE4 Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disea...
Show More Location
4th Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) PHASE4 The Swefot trial was designed to compare two treatment strategies for patie...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effect of Cilostazol on Rheumatoid Arthritis Patients PHASE2 The goal of this study is to evaluate the effect of cilostazol on Rheumatoi...
Show More Location
Al-Zahraa Hospital
Learn More & Join Trial
JAK2 Mutation May Predict Response and Guide First Line Treatment in Rheumatoid Arthritis NA This study included 76 newly diagnosed RA patients and 50 matched controls....
Show More Location
Mansoura University Hospital
Learn More & Join Trial
Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial. PHASE2 The goal of this multicenter, randomized, double-blind, placebo-controlled ...
Show More Learn More & Join Trial